Problematic guidance for politically controversial treatments – the case of medical marijuana

D. Indyk
Background: Guidelines should synthesize available data about indication and therapy, risk/benefit and cost-effectiveness based on best available evidence. Ideology and political interests may interfere with guideline development for cannabis. Data from randomized clinical trials suggest that cannabis,[for full text, please go to the a.m. URL]